GSK to cut drug prices for developing countries
The UK drugs maker is to cut significantly the prices of its medicine in emerging economies next spring, in a move to tap demand from the faster-growing economies as western markets stagnate
source : traxfer.ft.com
Related News:
- Kidney Cancer Drug Shows Promising Results
- AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
- Access Pharmaceuticals Initiates Program Applying Cobalamin Platform To SiRNA Drug Delivery
- Auxilium Announces U.S. Food And Drug Administration Approval For XIAFLEXTM For The Treatment Of Dupuytren’s Contracture
- Possible New Drug Target For Iron Deficiency, Overload
- Targeted Oral Drug Pazopanib Slows Progression Of Advanced Kidney Cancer
- Using Zebrafish As A Novel Platform For Drug Development
- PSivida CEO To Discuss Ocular Drug Delivery In Diabetic Retinopathy At 6th Annual Diabetes Conference January 22 In London
- Abnormal Lipid Levels Common in Teens
- FDA Adds Cardio Warnings to Weight Loss Drug
Details :
Submited at Sunday, November 29th, 2009 at 7:00 pm on Pharmaceutical by sofia
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...